Moderna’s billionaire CEO reaped nearly $400 million last year. He also got a raise.

Paolo Volpin, PhD, the Christopher and Mary Stratakis Professor of Corporate Governance and Accountability in the LeBow College of Business, was quoted in a Washington Post article about Moderna facing pushback for the increase in executive pay to the CEO of the pharmaceutical company.